Introduction: Analysis of sentinel nodes by OSNA uses a polymerase chain reaction to measure lymph node CK19 mRNA an epithelial marker for breast cells. Method: Prospective analysis of 54 patients between February 2010 to January 2011 was carried out. Sentinel node identification was by dual method of Patent Blue V and isotope injection into the breast. Nodes were cut into 4 slices A,B,C and D. Slices A and C were processed in OSNA and slices B and D underwent histological assessment by H&E staining. Tumour characteristics were identified for each patient and correlation between OSNA and histopathology was assessed. Results: One hundred and forty one nodes were taken from 54 patients. Exclusions on basis of weight and availability for comparison (25) left 116 nodes available for histological comparison. 18 were found to have macrometastases or micrometastases. The sensitivity and specificity of OSNA was 100% and 87% respectively. If on the basis of tissue allocation bias, we excluded micrometastases (9 cases), specificity was 97%. There was no correlation between node positivity, tumour grade, size or receptor status. Conclusion: OSNA saved 18 patients from a second procedure and has an excellent sensitivity and high specificity. Further prospective data collection continues. (4-48h) . 48 patients (92%) were discharged the same day and 4(8%) admitted. Admission indications were: conversion to open procedure 1 (2%), oxygen desaturation 1 (2%) and severe pain 2 (4%). Of these, 3 were discharged within 24h and 1 (2%) within 48h. Of 44 (85%) patients who responded to telephone survey, 11 (26%) reported no problems and 26 (60%) reported pain with adequate analgesia available. 1 (2%) patient represented with infected umbilical port site haematoma. Conclusions: This audit shows that a DCLC service can be established with good outcomes in a short time. Success of this service requires patient education, a competent operating team and set up for early discharge. Introduction: Mini C-arm fluoroscopy control is commonly used during surgical fixation of hand fractures and exposes staff and patients to the risks of radiation. Radiation protection is a responsibility of every surgeon. The documentation of the exposure time during every procedure (correlated radiation dose for Mini C-arm image intensifier: 7mGy/min) is a mandatory requirement (IR(MER)R2000). National guidelines for the maximum acceptable radiation dose in hand surgery do not exist, but recommendations in the peer reviewed literature (Pulvertaft Hand Centre) suggest a maximum of 30 seconds for open reduction /internal fixation (ORIF) and 10 seconds for k-wire fixation (MUA+k-wire). Our own departmental guidelines recommend 60 seconds for either procedure. We audited our performance according to these guidelines and improved our outcome by implementing simple changes. Methods & Results: Retrospective analyse of the Mini-C arm operator logbook over 3 months: ORIF (n¼29) compliance according to departmental guidelines: 100%, Pulvertaft guidelines: 97%; MUA+k-wire (n¼22) compliance 86% and 14%, respectively. Closing the audit loop: ORIF (n¼45), compliance according to departmental and Pulvertaft guidelines: 100%; MUA+k-wire (n¼36), compliance 100% and 17%, respectively (time period¼3months). Conclusion: We advocate that the use of Mini C-arm fluoroscopy should be subject to regular audits in every hand surgery department.
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'WHERE SHOULD LAPAROSCOPIC CHOLECYSTECTOMIES BE UNDERTAKEN?; CAN A RISK SCORE REDUCE THE RISK OF CONVERSION IN THE DAY-CASE SETTING Frances Mosley, John Griffith, Justin Davies, Mark Steward, Jay Gokhale, John May, Jonathan Robinson. Bradford Royal Infirmary, Bradford, UK Background and Method: With a changing pattern of healthcare provision procedures traditionally undertaken in an inpatient setting are increasingly occurring in independent sector treatment centres. We undertook a prospective study of 386 patients having a laparoscopic cholecystectomy to evaluate the effectiveness of a previously published risk-score1 (RSCLO score) in predicting which patients required conversion. Results: We found no significant difference between the RSCLO scores of those requiring conversion and those completed laparoscopically; with median scores of -6 and -7 respectively. We found significantly different rates of conversion between males and females and between those with and without previous upper abdominal surgery. Discussion and Conclusions: We found the RSCLO score to be an ineffective method of predicting which patients were at risk of conversion to an open cholecystectomy. We have devised a simple risk-score (Bradfordscore), when applied to our study population it divides the population into low-risk and high-risk groups with rates of conversion of 1.4% and 8.4% respectively (p <0.05).This scoring system allows the identification of the patients most at risk of conversion to an open procedure, and therefore less suited to a procedure outside a major hospital setting.
A CLINICAL AUDIT OF ENHANCED RECOVERY AFTER SURGERY (ERAS) ON FIVE SURGICAL WARDS AT NUH
Nick Simson, Charles Maxwell-Armstrong. University of Nottingham, Nottingham, UK Background: The majority of evidence for ERAS lies within colorectal surgery. Evidence for its benefit in other specialities is limited. Protocols for ERAS have been introduced in 5 specialities within NUH. Aims: To determine the application of ERAS principles within the identified specialities. Method: Patients undergoing colorectal, gynaecological, gynaecologic oncological, upper gastrointestinal and hepato-pancreaticobiliary surgery within defined ERAS protocols were audited prospectively. The primary outcomes were length of stay and ERAS success (determined by discharge in accordance with protocol). Results: 125 patients were audited. ERAS success ranged from 63.6% in gynaecology to 29.2% in gynaecologic oncology. Good compliance with protocol led to improved ERAS success in all specialities. Significant predictors of ERAS success (p<0.05) were demonstrated where patient population allowed. In colorectal surgery: ASA 2, laparoscopic over open surgery, eating breakfast on day 1, distance walked on days 1and 2, and removal of IVI, catheter and PCA/epidural as recommended by protocol. In gynaecology and gynaecologic oncology: eating a normal diet on day 1 and catheter removal on day 1. Discussion: The major issues affecting the ability to comply with the principles of ERAS were identified. These include poor patient motivation, inadequate anti-emetic control and sub-optimal patient mobilisation. They should be implemented and subsequent re-audit instituted.
0668 3D CONTRAST ENHANCED ULTRASOUND OF CAROTID ATHERO-SCLEROSIS Ankur Thapar, Joseph Shalhoub, David Owen, Alun Davies, Edward Leen. Imperial College, London, UK Contrast enhanced ultrasound is an emerging technology for assessment of carotid plaque morphology, perfusion and inflammation. 2D ultrasound is the current standard for plaque assessment. However it suffers from sampling error and section location is difficult to reproduce. Aim: A feasibility study to identify whether 3D imaging could address these problems. Method: 6 patients with 50-99% carotid stenosis were imaged following bolus injection of 2ml of intravenous SonoVue (Bracco, Italy) at a mechanical index of 0.27. The GE Logiq E9 ultrasound platform and the L6-16 probe were used to capture a 1 minute cine loop of 2D imaging, followed by a repeat injection and 3D acquisition at 40 seconds. Three dimensional plaque models were then constructed. Results: 3D imaging provided a mean of 5x1mm sections instead of 1 for visual plaque analysis. In one patient ulceration not detected on 2D contrast imaging was seen on 3D.
